Hamdard Laboratories India (Medicine Division) v. Unani Drugs Manufacturers Association (UDMA)

When a brand with decades of heritage takes on an industry association over allegedly misleading claims, you'd expect the courtroom drama to center on truth, trademarks, and market fairness. But sometimes, the most consequential ruling has nothing to do with who is right—and everything to do with who has the authority to decide. This case is a stark reminder that even the strongest trademark grievances can be derailed by a simple, foundational question: is this court the right court?

Hamdard Laboratories India (Medicine Division), a well-established name in the Unani medicine space, found itself at odds with the Unani Drugs Manufacturers Association (UDMA), a trade body representing manufacturers in the same industry. At the heart of the dispute was the iconic 'HAMDARD' trademark and the products associated with it. Hamdard alleged that UDMA was making misleading claims—specifically regarding market share figures and the categorization of Hamdard's products. Believing urgent intervention was necessary to protect its brand reputation and commercial standing, Hamdard moved for interim injunctions to restrain UDMA's allegedly misleading representations. When those applications were dismissed, Hamdard escalated the matter by way of appeal before the Delhi High Court.

Hamdard's position was rooted in the protection of its trademark rights and brand integrity. The company argued that UDMA's claims distorted the market reality, misrepresented Hamdard's standing in the Unani drugs industry, and improperly categorized its products in ways that could harm consumer perception and competitive positioning. For Hamdard, this was not merely a commercial squabble—it was a matter of intellectual property protection requiring swift judicial intervention. UDMA, on the other hand, contested the need for interim relief, and the broader legal architecture of the dispute itself became a focal point. The central friction was not just about trademarks or misleading statements, but about whether the forum hearing the matter possessed the institutional competence to adjudicate the underlying commercial complexities.

The Delhi High Court ultimately dismissed Hamdard's appeal, but not on the merits of the trademark or misleading claim allegations. Instead, the Court zeroed in on a fundamental procedural reality: the dispute was, at its core, a commercial dispute of a nature that required adjudication by a specialized Commercial Court. The Court reasoned that it was constrained in its ability to act in a matter where the substantive jurisdiction lay elsewhere. The outcome was defendant-favorable in effect—Hamdard's attempt to secure interim relief through the High Court was halted, and the matter was directed back to the appropriate Commercial Court for proper and expeditious resolution.

For founders, brand owners, and IP professionals, this case delivers a critical procedural lesson: the strength of your trademark claim matters far less if you file in the wrong forum. Before rushing to seek interim injunctions against competitors or trade associations, map out whether your dispute is truly an IP matter alone, or whether it is intertwined with broader commercial questions—market share, product categorization, trade representations—that will pull the case into the jurisdiction of a Commercial Court. Choosing the right battlefield from day one can save months of delay and prevent your strongest arguments from being sidelined by a simple jurisdictional technicality.